Archive for June, 2012

Mission and People

June 24th, 2012

I awoke this morning to front-page news about two criminal convictions—both concerning sexual abuse of children by trusted authorities, both in Pennsylvania, my home state, where I now live again. One involved a church leader in Philadelphia, the other a highly regarded assistant football coach at Penn State, where I am on faculty. The stories are jarring and disturbing and have made headlines around the world. The stories also carry lessons and reminders.

When I served in the U.S. Army, I learned (as all officers were taught) that nothing transcends the mission and the people. Society sets up many authorities, social structures, codes, and hierarchies: the military, law enforcement. civil service, the courts, religion, universities, medicine, and many others. People higher up in such hierarchies often enjoy privilege, elevated status, wealth, and recognition. Society imbues these people with trust and many perquisites and, in return, expects a code of conduct—such as dedication to one’s mission and people. Still, it is common for people and organizations to lose sight of these sacred trusts and focus instead on self gratification and taking care of one’s own: for example, police sometimes protect other officers before the public; doctors often protect our colleagues and trainees above our responsibility to their future patients.

It is reassuring that, after generations of neglect, society is now investigating and punishing the abuse of children. But physicians, educators, the clergy, and many others who benefit from elevated status in our community carry a range of obligations and expectations. We need to renew our vows every day in our own worlds—reminding ourselves of those who are vulnerable and depend on us. It comes back to our mission and our people.

-Alan J. Gelenberg, M.D.
Editor, Biological Therapies in Psychiatry
Shively/Tan Professor and Chair, Psychiatry, Penn State University
Editor-in-Chief, Journal of Clinical Psychiatry

NCDEU 2012

June 13th, 2012

I just attended the annual NCDEU meeting—this year in Phoenix, AZ. NCDEU stands for New Clinical Drug Evaluation Unit (formerly ECDEU, Early Clinical Drug Evaluation Unit) These are now meaningless acronyms, but it was originally a symposium of clinical psychopharmacology researchers funded by NIMH. NIMH has recently relinquished “ownership” of the meeting to the American Society of Clinical Psychopharmacology, but it, along with its sister institutes NIDA and NIAAA as well as the FDA, retains a partnership stake and roll [?a role] in the program.

No one was certain how this meeting, which many of us are devoted to, would survive the transition from NIMH’s leadership. But this year’s program, with ASCP in the lead, was a sparkling success: in attendance, participation, enthusiasm and—most of all—groundbreaking science.

Meetings evolve. ECDEU/NCDEU began as a methods-focused conclave in the early days of biological psychiatry. Over the decades, it evolved to incorporate understanding of brain function, psychosocial interventions, and combined treatments. NCDEU became a unique assembly of industry, government, and university scientists, regulators, teachers, and clinicians. The papers, posters, and panels contained cutting-edge information, but much of the spark came in the informal conversations, from which flowed new research ideas and collaborations.

This year’s agenda included news on innovative treatments and new data on old techniques and agents. A bold new diagnostic methodology, the NIMH Research Domain Criteria (RDoC) is shifting the focus from DSM categories to dimensions and traits, in the hope of mapping disorders to biological underpinnings and the human genome. Whether—and when—this will bear fruit in furthering understanding of brain disorders and creating new and personalized treatments remains to be seen. It could take years or even decades to unfold.

-Alan J. Gelenberg, M.D.
Editor, Biological Therapies in Psychiatry
Shively/Tan Professor and Chair, Psychiatry, Penn State University
Editor-in-Chief, Journal of Clinical Psychiatry

 

Overall, the information imparted at NCDEU 2012 was invigorating, and the energy in the meeting has never been higher. With the disclosure that I sit on ASCP’s board and have an abiding passion for its mission and NCDEU’s future, I encourage my faculty members and BTP readers to think about ASCP membership and attending NCDEU. BTP (and the Journal of Clinical Psychiatry) are partners with ASCP, which is a dynamic and growing organization. Coming away from this year’s meeting, I am very optimistic about psychiatry’s future.